Abstract
Fibrinogen altered by thrombin-catalyzed liberation of fibrinopeptide A was found to combine with native fibrinogen to form a cold-precipitable complex we have called "cryoprofibrin." The altered fibrinogen lacking fibrino-peptide A polymerized into fibrin, but not until conditions for equilibrium between its incorporation into both cryoprofibrin and fibrin were satisfied. At equilibrium, the concentration of cryoprofibrin was maintained at a threshold proportional to the concentration of fibrinogen. When the concentration of cryoprofibrin was below threshold, fibrin could be depolymerized and solubilized by fibrinogen with resultant formation of cryoprofibrin. Since threshold concentrations of cryoprofibrin appear necessary for precipitation of fibrin, the concentration of cryoprofibrin in plasma provides a basis for determining intravascular deposition of fibrin. Intravascular deposition of fibrin does not appear to occur normally in rabbits, because the concentration of cryoprofibrin in plasma from normal rabbits is far below the threshold for precipitation of fibrin. The applicability of cryoprofibrin as an indicator of fibrin deposition is demonstrated by the occurrence of levels of cryoprofibrin approaching the threshold for precipitation of fibrin in plasma from endotoxin-treated rabbits. The current concept that the fibrinogen molecule can dissociate into subunits can be used to explain the conversion of fibrinogen to cryoprofibrin. As one possibility, the two residues of fibrinopeptide A contained in fibrinogen may be located on two separate subunits of the molecule; cryoprofibrin is produced when one of these subunits is replaced by a subunit altered by loss of fibrinopeptide A. Recombination of native subunits with subunits altered by loss of A would counter dissociation of cryoprofibrin and inhibit polymerization of subunits lacking fibrinopeptide A. As an alternate mechanism, two residues of A may be liberated concurrently from a single subunit. Cryoprofibrin would then correspond to a fibrinogen molecule, containing a subunit with two residues of A, in combination with an altered molecule containing a subunit lacking two residues of A. Liberation of fibrinopeptide B did not contribute measurably to production of fibrin resulting from limited action of thrombin on rabbit fibrinogen. Both fibrin containing B but not A, and fibrin containing neither B nor A, as is produced by extensive action of thrombin, could be solubilized by fibrinogen. Thrombin, or another enzyme utilizing tosyl-L-arginine methyl ester as substrate, appeared reversibly to inhibit polymerization of fibrin containing fibrinopeptide B. This enzyme and fibrinogen were the only proteins appearing to inhibit polymerization in plasma from normal rabbits.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BAILEY K., BETTELHEIM F. R., LORAND L., MIDDLEBROOK W. R. Action of thrombin in the clotting of fibrinogen. Nature. 1951 Feb 10;167(4241):233–234. doi: 10.1038/167233a0. [DOI] [PubMed] [Google Scholar]
- BETTELHEIM F. R. The clotting of fibrinogen. II. Fractionation of peptide material liberated. Biochim Biophys Acta. 1956 Jan;19(1):121–130. doi: 10.1016/0006-3002(56)90393-6. [DOI] [PubMed] [Google Scholar]
- BRUNSON J. G., GAMBLE C. N., THOMAS L. Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. I. The effects produced in young and in mature animals by a single injection. Am J Pathol. 1955 May-Jun;31(3):489–499. [PMC free article] [PubMed] [Google Scholar]
- CASPARY E. A., KEKWICK R. A. Some physicochemical properties of human fibrinogen. Biochem J. 1957 Sep;67(1):41–48. doi: 10.1042/bj0670041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CREMER N., WATSON D. W. Influence of stress on distribution of endotoxin in RES determined by fluorescein antibody technic. Proc Soc Exp Biol Med. 1957 Jul;95(3):510–513. doi: 10.3181/00379727-95-23271. [DOI] [PubMed] [Google Scholar]
- DONNELLY T. H., LASKOWSKI M., Jr, NOTLEY N., SCHERAGA H. A. Equilibria in the fibrinogen-fibrin conversion. II. Reversibility of the polymerization steps. Arch Biochem Biophys. 1955 Jun;56(2):369–387. doi: 10.1016/0003-9861(55)90258-7. [DOI] [PubMed] [Google Scholar]
- LAKI K., GLADNER J. A., FOLK J. E. Some aspects of the fibrinogen-fibrin transition. Nature. 1960 Aug 27;187:758–761. doi: 10.1038/187758a0. [DOI] [PubMed] [Google Scholar]
- LOEWY A. G., DUNATHAN K., KRIEL R., WOLFINGER H. L., Jr Fibrinase. I. Purification of substrate and enzyme. J Biol Chem. 1961 Oct;236:2625–2633. [PubMed] [Google Scholar]
- LORAND L., JACOBSEN A. Studies on the polymerization of fibrin; the role of the globulin: fibrin-stabilizing factor. J Biol Chem. 1958 Jan;230(1):421–434. [PubMed] [Google Scholar]
- RASMUSSEN P. S. Purification of thrombin by chromatography. Biochim Biophys Acta. 1955 Jan;16(1):157–158. doi: 10.1016/0006-3002(55)90194-3. [DOI] [PubMed] [Google Scholar]
- SHERRY S., TROLL W. The action of thrombin on synthetic substrates. J Biol Chem. 1954 May;208(1):95–105. [PubMed] [Google Scholar]
- SMITH R. T. A heparin-precipitable fraction of human plasma. II. Occurrence and significance of the fraction in normal individuals and in various disease states. J Clin Invest. 1957 Apr;36(4):605–616. doi: 10.1172/JCI103460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- THOMAS L., GOOD R. A. Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon. J Exp Med. 1952 Dec;96(6):605–624. doi: 10.1084/jem.96.6.605. [DOI] [PMC free article] [PubMed] [Google Scholar]